Toll Free: 1-888-928-9744
Published: Apr, 2014 | Pages:
37 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Bausch & Lomb Incorporated - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Bausch & Lomb Incorporated - Product Pipeline Review - 2014', provides an overview of the Bausch & Lomb Incorporated's pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Bausch & Lomb Incorporated's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Bausch & Lomb Incorporated including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Bausch & Lomb Incorporated's human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Bausch & Lomb Incorporated's pipeline products Reasons to buy - Evaluate Bausch & Lomb Incorporated's strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Bausch & Lomb Incorporated in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Bausch & Lomb Incorporated's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Bausch & Lomb Incorporated and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Bausch & Lomb Incorporated - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Bausch & Lomb Incorporated and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 3 List of Figures 4 Bausch & Lomb Incorporated Snapshot 5 Bausch & Lomb Incorporated Overview 5 Key Information 5 Key Facts 5 Bausch & Lomb Incorporated - Research and Development Overview 6 Key Therapeutic Areas 6 Bausch & Lomb Incorporated - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Partnered Products 10 Partnered Products/Combination Treatment Modalities 11 Bausch & Lomb Incorporated - Pipeline Products Glance 12 Bausch & Lomb Incorporated - Late Stage Pipeline Products 12 Phase III Products/Combination Treatment Modalities 12 Bausch & Lomb Incorporated - Clinical Stage Pipeline Products 13 Phase II Products/Combination Treatment Modalities 13 Phase I Products/Combination Treatment Modalities 14 Bausch & Lomb Incorporated - Drug Profiles 15 brimonidine tartrate 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 latanoprostene bunod 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 mapracorat 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 bepotastine besylate 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 Bausch & Lomb Incorporated - Pipeline Analysis 23 Bausch & Lomb Incorporated - Pipeline Products by Target 23 Bausch & Lomb Incorporated - Pipeline Products by Route of Administration 24 Bausch & Lomb Incorporated - Pipeline Products by Molecule Type 25 Bausch & Lomb Incorporated - Pipeline Products by Mechanism of Action 26 Bausch & Lomb Incorporated - Recent Pipeline Updates 27 Bausch & Lomb Incorporated - Dormant Projects 31 Bausch & Lomb Incorporated - Locations And Subsidiaries 32 Head Office 32 Other Locations & Subsidiaries 32 Bausch & Lomb Incorporated - Key Manufacturing Facilities 35 Appendix 36 Methodology 36 Coverage 36 Secondary Research 36 Primary Research 36 Expert Panel Validation 36 Contact Us 37 Disclaimer 37
List of Tables Bausch & Lomb Incorporated, Key Information 5 Bausch & Lomb Incorporated, Key Facts 5 Bausch & Lomb Incorporated - Pipeline by Indication, 2014 7 Bausch & Lomb Incorporated - Pipeline by Stage of Development, 2014 8 Bausch & Lomb Incorporated - Monotherapy Products in Pipeline, 2014 9 Bausch & Lomb Incorporated - Partnered Products in Pipeline, 2014 10 Bausch & Lomb Incorporated - Partnered Products/ Combination Treatment Modalities, 2014 11 Bausch & Lomb Incorporated - Phase III, 2014 12 Bausch & Lomb Incorporated - Phase II, 2014 13 Bausch & Lomb Incorporated - Phase I, 2014 14 Bausch & Lomb Incorporated - Pipeline by Target, 2014 23 Bausch & Lomb Incorporated - Pipeline by Route of Administration, 2014 24 Bausch & Lomb Incorporated - Pipeline by Molecule Type, 2014 25 Bausch & Lomb Incorporated - Pipeline Products by Mechanism of Action, 2014 26 Bausch & Lomb Incorporated - Recent Pipeline Updates, 2014 27 Bausch & Lomb Incorporated - Dormant Developmental Projects,2014 31 Bausch & Lomb Incorporated, Other Locations 32 Bausch & Lomb Incorporated, Subsidiaries 32 Bausch & Lomb Incorporated, Key Manufacturing Facilities 35
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.